| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |